Respiratory syncytial virus

Real World Evidence Impact of universal immunization with Nirsevimab

Burden of Disease

RSV History

RSV

All Infant Protection

Nirsevimab : Clinical Experience

RSV Burden in Infants

Nirsevimab International Recommendation

Rattle

2024 RSV International Congress - ESPID

2024 RSV International Congress ECMMID

Beyfortus®, an innovative immunization

Beyfortus in Action

Beyfortus in Action ECMMID

Saudi initiatives on Bronchiolitis Recommendations

The first choice of RSV prevention is Nirsevimab; alternatively, palivizumab is to be considered in case of unavailability of Nirsevimab.

Implementing Beyfortus successfully (US)

Implementing Beyfortus successfully (ES)

Implementing Beyfortus successfully

Implementing Beyfortus successfully (FR)